Bryan C Markinson, DPM Email Bryan Markinson
- ASSOCIATE PROFESSOR | Orthopedics
- ASSISTANT PROFESSOR | Pathology, Molecular and Cell Based Medicine
- Orthopedics and Orthopedic Surgery
- Hospital Affiliation
- The Mount Sinai Hospital
- Center for Advanced Medicine 212-824-7160 212-824-7160
Dr. Markinson is a 1981 graduate of the New York College of Podiatric Medicine. He completed a Podiatric surgical residency at the New York College of Podiatric Medicine and affiliated hospitals in 1982, after which he trained as a Fellow in Podiatric Medicine at the same institution, ending in June 1983. That program focused on dermatologic, rheumatologic, and diabetic foot disorders. He then received an academic appointment at his alma mater, where he currently is an adjunct Professor in the Department of Podiatric Medicine. He started a private practice in Brooklyn, New York, in 1984. He was Board Certified by the American Board of Podiatric Orthopedics and Primary Podiatric Medicine in 1989, and voluntarily completed the re-certification process in 2003.
From 1993 to 1995, Dr. Markinson received additional training in podiatric pathology at the University of Medicine and Dentistry of New Jersey, in the division of dermatopathology, under the direction of W. Clark Lambert, MD, PhD. He then started the Podiatric Pathology service at the Mount Sinai Medical Center in New York City.
He is a Fellow of the American Society of Podiatric Dermatology, and was elected President of that organization in December 2003, his term ending in September 2005. In 2004, Dr. Markinson began serving on the board of the Council for Nail Disorders, and affiliate of the American Academy of Dermatology.
In 1999, he joined the full-time faculty practice at the Leni and Peter W. May Department of Orthopedic Surgery of the Mount Sinai School of Medicine as the Chief of Podiatric Medicine and Surgery. This enabled the Mount Sinai of Queens Podiatric Surgical Residency to expand from four to twelve residents, and from a two year program to a three year program.
Dr. Markinson's special areas of interest are podiatric skin diseases and tumors, including early diagnosis of pedal melanoma and fungal diseases of the skin and nails, pedal dermatitis, diabetic foot problems, foot surgery, and the special foot health problems of the elderly. He lectures extensively and enjoys participating on various advisory boards in the pharmaceutical industry.
American Board of Podiatric Medicine
- Achilles Tendinopathy
- Amputation Of The Foot Or Toe
- Ankle Sprain
- Athlete's Foot
- Bone Spurs
- Corns / Calluses
- Diabetic Foot Ulcer
- Diabetic Neuropathy
- Epidermal Cyst
- Flat Foot
- Foot Deformities
- Foot Fracture
- Foot Ulcers
- Foot and Ankle Arthritis
- Foot and Ankle Tendonitis
- Foot or Ankle Tumor / Neuroma
- Ganglion Cyst
- Hallux Rigidus
- Hammer Toe
- Heel Pain
- High-Arched Feet
- Ingrown Toenail Removal
- Joint Injection
- Morton's Neuroma
- Navicular Fracture
- Plantar Fasciitis
- Plantar Warts
- Posterior Tibial Tendinopathy
- Sesamoid Fracture
- Shin Splint
- Skin Biopsy
- Skin Lesion Removal
- Soft Tissue Mass
- Toe Fracture
- Toe Pain
- Toenail Fungus
- Toenail Removal
DPM, New York College of Podiatric Med.
Residency, Podiatric Surgery
New York College of Podiatric Medicine
Fellowship, Medical Science
New York College of Podiatric Med.
Univ of Medicine & Dentistry of NJ
podiatric skin diseases pedal melanoma fungal diseases diabetic
His special areas of interest are podiatric skin diseases, including early diagnosis of pedal melanoma and fungal diseases of the skin and nails, soft tissue masses, diabetic foot problems, foot surgery, and the special foot health problems of the elderly. He works closely with specialists of all types in the prevention and management of podiatric manifestations of diabetes, vascular disorders, arthritic diseases, neurological problems, and other systemic ailments.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Markinson during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- iRemedy, INC.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.